| Role of m6A modification in dysregulation of Wnt/β-catenin pathway in cancer P Tabnak, Y Ghasemi, M Natami, R Khorram, M Ebrahimnezhad Biomedicine & Pharmacotherapy 157, 114023, 2023 | 8 | 2023 |
| FOXO1, a tiny protein with intricate interactions: Promising therapeutic candidate in lung cancer M Ebrahimnezhad, M Natami, GH Bakhtiari, P Tabnak, N Ebrahimnezhad, ... Biomedicine & Pharmacotherapy 169, 115900, 2023 | 7 | 2023 |
| Forkhead box transcription factors (FOXOs and FOXM1) in glioma: from molecular mechanisms to therapeutics P Tabnak, A Hasanzade Bashkandi, M Ebrahimnezhad, M Soleimani Cancer Cell International 23 (1), 238, 2023 | 4 | 2023 |
| Unveiling the potential of FOXO3 in lung cancer: From molecular insights to therapeutic prospects M Ebrahimnezhad, A Valizadeh, M Majidinia, P Tabnak, B Yousefi Biomedicine & Pharmacotherapy 176, 116833, 2024 | | 2024 |
| Polyphenols Modulate the miRNAs Expression that Involved in Glioblastoma. M Rezaie, M Nasehi, M Shimia, M Ebrahimnezhad, B Yousefi, M Majidinia Mini Reviews in Medicinal Chemistry, 2024 | | 2024 |
| Thymoquinone Increases the Sensitivity of SW‐480 Colon Cancer Cells to 5‐Fluorouracil N Zeinali, V Mahmoudzadeh, A Anarjani, M Ebrahimnejad, B Yousefi, ... BioMed Research International 2024 (1), 6231095, 2024 | | 2024 |
Peyman TabnakImmunology Research Center, Tabriz University of Medical Science在 tbzmed.ac.ir 的电子邮件经过验证
